UNSPSC 51333201: Aldesleukin

This classification denotes a therapeutic interleukin-2 with the molecular formula C690H1115N177O202S6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M89N0Q7EQR, more generally known as aldesleukin. European Medicines Agency schedules aldesleukin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05303MIG. The term ALDESLEUKIN is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 5, no. 3 1991, list 31.

Most nations schedule aldesleukin under HS 35040000 and SITC 59225. As of Q4 2014, ALDESLEUKIN remains the US FDA Preferred Term for this commodity. Aldesleukin bears US NLM identifiers UMLS ID C0218986 and NCI Concept Code C1498. SMILES: NONE.

UNSPSC 51333201 Aldesleukin is a Commodity code that in recent state and local procurement activity encompasses pharmaceutical products and medical supplies for public health initiatives, though the single recent opportunity tagged to this code—Seminole County, Florida's June 2026 IFB for naloxone and drug deactivation systems—appears to diverge materially from the code's nominal pharmaceutical scope. The opportunity solicits naloxone (an opioid-overdose reversal medication) and safe drug deactivation systems for community health support, procured through competitive sealed bid with annual quantities of 1,900 units of naloxone and 800 deactivation systems delivered quarterly. The issuing body is a county health or public-safety function; the procurement framework includes standard state and local requirements such as drug-free workplace certification, E-Verify compliance, workers' compensation and commercial general liability insurance, and a three-month probationary termination clause. The contract term runs two years with a one-year renewal option, and the procurement may draw FEMA funding, introducing federal compliance overlays including Clean Air Act and Federal Water Pollution Control Act adherence.

Geographic activity is limited to Florida based on current records. Seminole County posted the IFB on June 30, 2026, with a response deadline of July 26, 2023—note the inconsistency in posted and due dates within the source record itself. Vendors must submit bids electronically through Seminole County's e-Procurement Portal and include all shipping and delivery costs in their proposals. The mismatch between the code's pharmaceutical name (Aldesleukin, a recombinant interleukin-2 immunotherapeutic agent) and the actual procurement (naloxone and drug deactivation systems) suggests either a tagging error in the opportunity record or that this UNSPSC code sees little activity aligned with its nominal scope in recent state and local solicitations.